Why investors have put $100m behind Australian biotech’s ‘Trojan horse’ for cancer
From deathbed promise to cancer breakthrough: Why big pharma is watching this Aussie biotech in Phase-2 trials. Dr Jennifer MacDiarmid and Dr Himanshu Brahmbhatt are both working on animal vaccines for the CSIRO in the late 1990s when one of their best lab technicians starts coughing blood at the bench. Rushed to hospital, the 40-year-old […]